Skip to Content

Pharmacy Practice Residency Programs

The Memphis VA Medical Center, located at 1030 Jefferson Ave in Memphis Tennessee, capital of blues and barbeque, is part of the VISN 9 VA Healthcare Network. It is a 250-bed facility with an additional 60-bed Spinal Cord Injury Unit, numerous specialty clinics, with primary care services located at the main facility and nine community-based outpatient clinics. The facility is accredited by the Joint Commission and is classified as a complex, Level I Facility.

Memphis VAMC Entrance

The Memphis VA Medical Center is a teaching hospital, providing a full range of patient care services, state-of-the-art technology and many educational and research opportunities. Comprehensive health care is provided through primary, secondary, and tertiary care, in areas of medicine, surgery, psychiatry, physical medicine and rehabilitation, spinal cord injury, neurology, oncology, dentistry, and geriatrics. Specialized outpatient services are provided through general, specialty, and subspecialty outpatient clinics including a women's health center. Services are available to more than 196,000 veterans living in a 53-county tristate area (Tennessee, Arkansas, and Mississippi).

The Memphis VA Medical Center long-standing tradition of providing clinical pharmacy services to the medical center and training highly qualified pharmacy residents. The program was first accredited in 1963 and over 260 residents have completed training. Pharmacy residency training programs at the Memphis VA Medical Center have allowed residents to train at an advanced level of practice in a progressive pharmacy environment. Clinical pharmacy specialists contribute to clinical services throughout the medical center and provide a wide variety of clinical pharmacy experiences including medical ICU, surgical ICU, cardiology ICU, nutrition support, internal medicine, geriatrics, palliative care, spinal cord injury, hematology/oncology, emergency medicine, practice management, pharmacoeconomics, psychiatry, primary care and home based primary care. Longitudinal clinic experiences include hypertension, hyperlipidemia, pain management, heart failure, emergency medicine, neurology, rheumatology, hematology/oncology, polypharmacy/transitions of care, geriatrics, HIV, and Hepatitis C.

Pharmacy residents are provided the opportunity to accelerate their growth beyond entry-level professional competence in patient-centered care, pharmacy operational services, and leadership skills that can be applied in any position and in any practice setting.  Residents acquire substantial knowledge required for skillful problem solving, refine their problem-solving strategies, strengthen their professional values and attitudes, and advance the growth of their clinical judgment.  The instructional emphasis is on the progressive development of clinical judgment, a process begun in the advanced pharmacy practice experiences (APPE or clerkships) of the professional school years but requiring further extensive practice, self-reflection, and shaping of decision-making skills fostered by feedback on performance.  The residency year provides a productive environment for accelerating growth beyond entry-level professional competence through supervised practice under the guidance of model practitioners.  Specifically, residents will acquire these skills and competencies: managing and improving the medication-use process; providing evidence-based, patient-centered medication therapy management with interdisciplinary teams; exercising leadership and practice management; demonstrating project management skills; providing medication and practice-related education/training; and utilizing medical informatics.

The VAMC Memphis offers three ASHP accredited residency programs, a PGY1 Pharmacy Practice Residency as well as two PGY-2 programs, one in Internal Medicine and one in Ambulatory Care.

VAMC Memphis Welcomes our 2023-2024 PGY1 and PGY2 Pharmacy Residents

2023-2024 PGY1 and PGY2 Pharmacy Residents
Julia Dorothy Bommarito

Julia Dorothy Bommarito grew up in New Orleans, LA. A life-long resident of New Orleans, Julia attended Mount Carmel High School and Loyola University before pharmacy school. Julia completed her pharmacy degree at Xavier University’s College of Pharmacy in New Orleans, where she was awarded with the Xavier University College of Pharmacy Award for Excellence in Patient Care and Communication. Her pharmacy interests include ambulatory care and outpatient services— work that can connect her with her community. When Julia isn’t spending time with her two cats Gus and Ollie, she loves to cook, tend to her house plants, do yoga, and watch reality television (The Real Housewives is her favorite). Julia is honored and excited to explore Memphis and grow her professional skills as a part of the VAMC Memphis residency program.

Victoria “Tori” Ware Bush

Victoria “Tori” Ware Bush was born and raised in Indianola, MS. Tori attended Indianola Academy, and she completed undergraduate prerequisites at Mississippi State University in Starkville, MS. Tori obtained her Bachelor of Science in Pharmaceutical Sciences and Doctor of Pharmacy from University of Tennessee College of Pharmacy in Memphis, TN. In pharmacy school, Tori was a member of APhA-ASP and Kappa Psi fraternity. She also enjoyed working at a small independent pharmacy in Southaven, MS throughout her time in pharmacy school. Her current pharmacy interests include critical care, internal medicine, and cardiology. In her spare time, Tori enjoys spending time with her family and friends, watching her nieces and nephew play sports, exercising, and gardening. Tori is so excited to start her career as a pharmacy resident at the VAMC Memphis, and she is honored to be a part of such a prestigious program.

Te’a Nicole Fehrenbacher

Te’a Nicole Fehrenbacher or “Nikki” was born in Paducah, KY. She attended high school at Marshall County High School in Benton, KY and completed her pre-pharmacy coursework at the University of Louisville. Nikki moved to Lexington, KY to complete her pharmacy degree at the University of Kentucky College of Pharmacy. In pharmacy school, Nikki was a member of the UK Student National Pharmaceutical Association (SNPhA), Mindfulness in Newly Developing Students (MINDS), Future Pharmacists for Veterans (FP4V), Student College of Clinical Pharmacists, Kentucky Alliance of Pharmacy Students (KAPS), American Pharmacists Association (APhA, KPhA), American Society of Health-System Pharmacists (ASHP, KHP), and the Rho Chi Honor Society. Her pharmacy interests include ambulatory care and cardiology. In her spare time, Nikki enjoys reading, spending time with friends and family, running, and hiking. She is grateful to be a part of the VAMC Memphis residency program and is excited to begin her career as a pharmacist.

Lauren Jackson

Lauren Jackson was born and raised in Birmingham, Alabama. After graduating from Oak Mountain High School, she obtained her Bachelor of Science in Pharmacy Studies from Samford University in Birmingham, Alabama. Lauren continued her education at Samford University receiving her Doctor of Pharmacy and Master of Public Health degrees. In pharmacy school, Lauren was a member of APhA-ASP, SSHP, ASHP and Rho Chi. Lauren completed her first year of post-graduate training at the Lt. Col. Luke Weathers Jr. VA Medical Center. In her spare time, she enjoys the outdoors, planting, and spending time with friends and family. Lauren is excited to continue her training while serving the veterans of the Lt. Col. Luke Weathers Jr. VA Medical Center as a PGY-2 Ambulatory Care resident.

Sydney Kingston

Sydney Kingston was born in Columbia, MD. She grew up in the St. Louis, MO area and spent her high school years in the Dallas, TX area. She attended high school at Wakeland High School in Frisco, TX and earned her Bachelor of Science degree from the University of Memphis, where she also played for the women’s soccer team. Sydney remained in Memphis to complete her pharmacy degree at the University of Tennessee College of Pharmacy. In pharmacy school, Sydney was a member of Phi Delta Chi, APhA-ASP, and Rho Chi. Her pharmacy interests include critical care/nutrition, internal medicine, and oncology. In her spare time, Sydney enjoys spending time with friends and family, watching sports, and playing with and snuggling her cats and dog. She is honored to be a part of the VAMC Memphis residency program and is excited to begin her career as a pharmacist.

Taylor Linburn Littlejohn

Taylor Linburn Littlejohn was born and raised in Memphis, TN. He attended high school at Collierville High School in Collierville, TN and earned his Bachelor of Science degree at the University of Memphis. Taylor decided to stay in Memphis to pursue a Doctor of Pharmacy from the University of Tennessee Health Science Center. In pharmacy school, Taylor served as chair of the OTC Medicine Safety Committee in APhA-ASP and participated in the college’s Admissions Committee. His pharmacy interests include emergency medicine, internal medicine, and oncology. In Taylor’s spare time he is involved in the local music scene of Memphis and plays guitar in a band. Taylor and his wife love going to local restaurants and shows, making the most of all that the city of Memphis has to offer. He is honored to be a Resident at the VAMC and is excited to begin his career in pharmacy in the city that built him.

Nicolas Tyler Malik

Nicolas Tyler Malik was born in Chicago IL. He grew up playing all different types of sports, traveling all across the country with his various teams. He attended Montini Catholic High School in Lombard, IL and went to undergraduate school and pharmacy school at Creighton University in Omaha, NE to earn his pharmacy degree. Throughout pharmacy school Nic was a member of APhA-ASP, SSHP, Phi Lambda Sigma and Kappa Psi. His interest in pharmacy includes cardiology and critical care. In his spare time, Nic enjoys spending time with friends, working out, eating lots of great food and keeping up to date with all the new Star Wars material. He is honored to be a part of the VAMC Memphis residency program and is excited to begin her career as a pharmacist.

Joshua William Skaggs

Joshua William Skaggs was born in St. Louis, MO. He was raised 40 minutes west of St. Louis in a town called Union, MO where he attended high school. After high school he moved north to Maryville, MO where he attended Northwest Missouri State University to earn a biochemistry degree. Joshua then returned to St. Louis to pursue his pharmacy doctorate at the St. Louis College of Pharmacy. During his time in pharmacy school, Joshua worked at Mercy Hospitals South where he developed a love for ambulatory care, infectious disease, and cardiac medicine. In his free time, Joshua spends time with friends and family doing various activities. Joshua is also an avid reader and fisherman, often listening to audio books while finding new places to fish. He is very excited to continue his professional career in pharmacy at the VAMC Memphis ambulatory care program and is looking forward to the new knowledge and experiences he will gain at the program.

Caroline Williams

Caroline Williams has been a Tennessee resident her entire life. Born in Jackson, TN and raised in Huntingdon, TN, she graduated from Huntingdon High School. She stayed in west Tennessee and earned her Bachelor of Science degree in biology from the University of Tennessee at Martin. Caroline then attended the University of Tennessee Health Science Center College of Pharmacy on the Memphis campus. In pharmacy school, Caroline was a member of APhA-ASP, Phi Delta Chi, Phi Lambda Sigma, and Rho Chi. In her spare time, Caroline enjoys baking and decorating cakes, being a dog mom to her cocker spaniel, Calvin, and attending concerts/music festivals. Caroline is excited to continue her pharmacy training as part of the Internal Medicine PGY2 program at the Lt. Col. Luke Weathers Jr. VA Medical Center.

Dana Williams

Dana Williams was born in Bethesda, Maryland. As part of an active-duty Air Force family, she moved frequently when she was younger. She attended Ocean Springs High School and went on to obtain her Bachelor of Science in Pharmaceutical Sciences from The University of Mississippi. She continued her coursework at The University of Mississippi, receiving her Doctor of Pharmacy. While she was in pharmacy school, she was a member of APhA-ASP, ACCP, and ASHP. In her spare time, Dana enjoys spending time with friends and family and her dog Louis, traveling, and trying new baking recipes. Dana is honored and grateful to be a part of the Internal Medicine PGY2 program at the Memphis VA Medical Center.

PGY1 Program

PGY1 Program Description

The VAMC Memphis has been training Pharmacy Practice residents since 1963. The PGY-1 residency is a 12-month post-Doctor of Pharmacy training program accredited by ASHP. The goals of this residency are to enable pharmacists to develop the knowledge and experience necessary to provide pharmaceutical care to both ambulatory and hospitalized patients with a strong emphasis on developing clinical skills. The opportunity for residents to participate in innovative practice areas is a direct result of VAMC Memphis’ long history of clinical pharmacy involvement and the unique practice environment that is found in a federal healthcare facility. Upon completion of the PGY-1 program, the resident will be eligible for board certification and a PGY-2 pharmacy residency training program.

Full-time clinical services are provided by clinical pharmacy specialists in the following areas in which residents can train, working with experienced pharmacist practitioners:

  • Ambulatory Care
  • Geriatrics
  • Internal Medicine
  • Infectious Disease/Antimicrobial Stewardship
  • Inpatient Mental Health
  • Outpatient Mental Health
  • Neurology
  • Nutritional Support
  • Medical Intensive Care
  • Surgery Intensive Care
  • Cardiology
  • Rheumatology
  • Spinal Cord Injury
  • Palliative Care
  • Home Based Primary Card
  • Emergency Department
  • Hematology/Oncology

Residents have ongoing ambulatory clinic involvement in three or more practice areas. Residents work closely with the Pharmacy Director to develop practice management skills with emphasis on all aspects of clinical pharmacy services. Training schedules include flexibility to allow residents to pursue areas of personal interest. Research and scholarly activities are an important aspect of the VAMC Memphis Residency program, and the residents will complete projects that will improve patient care. Instructional and educational opportunities are available for residents to develop teaching skills by presenting lectures and small group discussions.

Program Purpose

The purpose of the Memphis Veterans Affairs Medical Center PGY1 Pharmacy Residency Program is to build on the Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions and to prepare graduate pharmacists for the practice of pharmacy as exemplified by the concepts of pharmaceutical care. The pharmacist completing the residency training program will independently and confidently manage patient disease states and drug therapy focused on achieving appropriate patient outcomes.  The pharmacist will be a proficient member of the healthcare team, proactively manage practice issues, possess marketable practice skills, and exhibit effective teaching and communication skills. The pharmacist will commit to continuous lifelong learning and the advancement of the pharmacy profession. Upon completion of the PGY1 program, the resident will be eligible for board certification and a postgraduate year two (PGY2) pharmacy residency training program.

Program Structure

Required Rotations (4 weeks each)

  • Ambulatory Care
  • Medical Intensive Care Unit
  • Surgical Intensive Care Unit/Nutrition Support
  • Geriatrics
  • Internal Medicine
  • Practice Management/Drug Information/Pharmacoeconomics

 

Elective Rotations (4 weeks each)

  • Repeat of core rotation(s)
  • Cardiology
  • Outpatient Mental Health
  • Inpatient Mental Health
  • Substance Use Disorder/Residential Rehabilitation Therapy Program
  • Spinal Cord Injury
  • Home Based Primary Care
  • Palliative Care
  • Outpatient Pain Management
  • Hematology/Oncology
  • Antimicrobial Stewardship/ID

 

Longitudinal Ambulatory Care Experiences (2 months each, resident chooses three)

  • Pain Coping Group
  • Hypertension Clinic
  • Heart Failure Clinic
  • Lipid Clinic
  • GI/Hepatitis C

 

Other longitudinal learning experiences

  • Orientation to all aspects of the health system’s pharmacy services, residency and PharmAcademic
  • ACLS/BLS Certification
  • Adverse Drug Reaction Monitoring
  • Formulary Management
  • Antibiotic Surveillance
  • Applied Pharmacokinetics
  • Patient Education
  • Pharmaceuticals preparation and dispensing, applied pharmacy practice
  • On a rotating basis, each resident serves as Chief Resident concurrent with other rotations

 

Other required activities

  • Pharmacotherapy Presentations/CE program
  • Newsletter article
  • Medication Usage Evaluation
  • Journal Club
  • IRB approved research project 
  • University of Tennessee College of Pharmacy Teaching Learning Program 
  • Clinical/Operational Staffing on a rotational basis

 

 Benefits

  • Two and one-half weeks paid vacation and sick leave plus federal holidays 
  • Participation in VA Plans/Programs (i.e. health insurance)
  • Three days paid interview leave and paid leave to attend and participate in state and national pharmacy meetings

 

Application Process

Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy

The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.

PhORCAS application requirements: 

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

 

Summary

Type/Duration: PGY1 Pharmacy Residency/12 months

Number of Positions: 6

Application Deadline:  January 1

Estimated Stipend:  $47,397                

Interview Required: Yes

ASHP Program Code: 54200

NMS Match Code: 190213

 

Contact Information

For more information about the PGY1 Pharmacy Residency Program, please contact:

Joshua Sullivan, PharmD, BCACP (josh.sullivan@va.gov) or Sara Layman, PharmD, BCPC (sara.layman@va.gov)

PGY2 Ambulatory Care Program Description

PGY2 Ambulatory Care Program Description

The VAMC Memphis Post Graduate Year Two Ambulatory Care Pharmacy Residency is a 12-month training program accredited by the American Society of Health-System Pharmacists. This program is a post-Doctor of Pharmacy program to be completed after an ASHP accredited PGY1 residency. The goal of this residency is to enable pharmacists to develop the knowledge and experience necessary to provide pharmaceutical care to ambulatory patients with a strong emphasis on developing and mastering clinical skills in the outpatient setting. The resident will function independently and collaboratively with team members to achieve optimal drug therapy outcomes. The resident will be responsible for pharmacotherapy decisions, patient counseling, writing progress notes and monitoring drug therapy. The resident will also create and implement a clinical service, participate in several educational programs and will have the opportunity for didactic teaching and precepting students to develop teaching skills. Residents work closely with the Pharmacy Director and Residency Program Director to develop practice management skills with emphasis on all aspects of clinical pharmacy services. Through a partnership with the University of Tennessee College of Pharmacy, residents will participate in a teaching and learning program. Experienced clinical pharmacy specialists provide clinical services in the following areas: Primary Care, Home Based Primary Care, Geriatrics, Neurology, Cardiology, Rheumatology, Emergency Room, Memory Clinic, Pain Management, Hematology/Oncology, HIV and Hepatitis C. Residents have the opportunity to train in all of these sites. Training schedules include flexibility to allow residents to pursue areas of personal interest. Research and scholarly activities are an important aspect of the VAMC Memphis Residency program, and residents participate in projects that will improve patient care. As part of the nation's health care system, the Memphis VA also interacts with other VA pharmacy programs for a continuous sharing of innovative approaches to improve patient drug therapy outcomes.

Program Purpose

The purpose of the VAMC Memphis PGY2 Ambulatory Care Pharmacy Residency Program is to build on the Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency program to contribute to the development of clinical pharmacists in Ambulatory Care. Residents will have opportunities to function independently as practitioners and work collaboratively as members of the healthcare team by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care that optimizes medication therapy. The PGY2 Ambulatory Care resident will exercise proficiency in communication and education of other health care professionals, patients and the community. Upon completion of the PGY2 Ambulatory Care residency, the resident will be prepared to establish collaborative interdisciplinary ambulatory care practices, possess competencies that qualify them for clinical pharmacist and/or faculty positions and position them to be eligible for attainment of board certification in Ambulatory Care (BCACP).

Program Structure

Required Rotations

  • Pharmacotherapy Clinic I (8 weeks)
  • Pharmacotherapy Clinic II (8 weeks)
  • Pharmacotherapy Clinic III (8 weeks)
  • Home Based Primary Care (HBPC)/Spinal Cord (4 weeks)
  • Anticoagulation (4 weeks)
  • Outpatient pain management (4 weeks)
  • Outpatient Mental Health (4 weeks)
  • Practice Management (4 weeks)

 

Elective rotations (4 weeks each):

  • Cardiology
  • Geriatrics (long-term care)
  • Hematology/Oncology
  • Palliative Care/Pain Management
  • ID/Hepatitis C
  • Infectious Disease/Antimicrobial Stewardship
  • Internal Medicine/Transitional Care
  • Substance Use Disorder/Residential Rehabilitation Therapy Program

 

Required, year-long, continuous experiences

  • Adverse Drug Reaction Monitoring
  • Practice Management/Formulary Management
  • Patient Education
  • Project Management/Research
  • Resident Pharmacotherapy Clinic
  • Teaching/Precepting

 

Elective pharmacotherapy longitudinal experiences. Residents will choose from the following to participate in during pharmacotherapy clinics and other elective months:

  • Hypertension Clinic
  • Lipid Clinic
  • Heart Failure Clinic
  • Endocrinology Clinic
  • GI/Hepatitis Clinic
  • Nephrology Clinic

 

Other required activities:

  • Pharmacotherapy Presentations (2 hours, CE)
  • Journal Club
  • IRB approved research project 
  • University of Tennessee College of Pharmacy Teaching Learning Program 
  • Ambulatory Care Staff Meeting Presentations
  • Outpatient pharmacy operational/transitions of care staffing on a rotational basis

 

Benefits

  • Two and one-half weeks paid vacation and sick leave plus federal holidays
  • Participation in VA Plans/Programs (health insurance, etc.)
  • Three days paid interview leave
  • Paid leave to attend and participate in state and national pharmacy meetings

 

Application Process
Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist

The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.

PhORCAS application requirements:

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

 

Summary

Type/Duration                           PGY2 Ambulatory Care Residency/12 months

Number of Positions:                2

Application Deadline:                 January 7

Estimated Stipend:                    $50,679            

Interview Required:                    Yes (with formal presentation)

ASHP Program Code: 54053

NMS Match Code: 735465

 

Contact Information

For more information about the PGY2 Ambulatory Care Residency Program, please contact:

Katelyn Wassell, PharmD, BCACP

Clinical Pharmacy Practitioner – Ambulatory Care

PGY2 Ambulatory Care Residency Program Director

Lt. Col. Luke Weathers Jr. VA Medical Center

1030 Jefferson Ave

Memphis, TN

Phone:

Email: Katelyn.wassell@va.gov

 

PGY2 Internal Medicine Program

Introduction

The VAMC Memphis PGY2 Pharmacy Residency in Internal Medicine is a 12-month training program that aims to train highly motivated and qualified pharmacists to provide exceptional care for adult internal medicine patients. The practice setting is a 250-bed tertiary VA hospital in Memphis, TN. The pharmacy resident will work as an integral member of the healthcare team, along with medical residents and fellows affiliated with the University of Tennessee Health Science Center. The resident will have the opportunity to develop practice management skills, participate in educational programs, provide formal lectures, and precept pharmacy students. The resident will also participate in projects designed to improve patient care and outcomes. Flexible training schedules allow the resident to pursue areas of personal interest while meeting the educational goals of the program. Appointment is within the Federal government, and residents are therefore subject to all regulations and requirements of the Federal system.

Purpose

The purpose of the PGY2 Internal Medicine Program is to build upon the resident’s Doctor of Pharmacy education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in Internal Medicine. The PGY2 Internal Medicine residency provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 Internal Medicine pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Learning Experiences  

Core rotations:

  • Orientation (if PGY1 not completed at Memphis VAMC)
  • Internal Medicine I (8 weeks)
  • Internal Medicine II (8 week)
  • Ambulatory Care (1 month)
  • Cardiology (1 month)
  • Critical Care (1 month)
  • Geriatric Medicine (1 month)

Elective rotations:

  • Repeat of any required rotation
  • Infectious Disease/Antimicrobial Stewardship
  • Inpatient Mental Health 
  • Nutrition Support
  • Palliative Care/Pain Management

Additional requirements: 

  • Practice Management Longitudinal
    • Chief Resident (on a rotating basis with other residents)
    • Participation in formulary management/PADRs
    • Quality improvement project/protocol and/or order set development
  • IRB-approved research project (including written manuscript and presentation at MidSouth Pharmacy Residents Conference)
  • Pharmacotherapy CE presentations (2)
  • Journal club presentations (2)
  • Local or regional presentation/poster/abstract or case report 
  • Teaching Certificate Program (optional, if not completed PGY1 year)
  • Weekend clinical, TOC and operation inpatient staffing
  • Participation in Resident-Preceptor Mentor program

Benefits

  • Two and one-half weeks paid vacation and sick leave plus federal holidays 
  • Participation in VA Plans/Programs (health insurance, etc.)
  • Three days paid interview leave 
  • Paid leave to attend and participate in state and national pharmacy meetings

Application Process

Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist

The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.

PhORCAS application requirements:  

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

Summary

Type/Duration: PGY2 IM Residency/12 months 
Number of Positions: 1-2
Application Deadline: January 6, 2023
Estimated Stipend: $50,679    
Interview Required: Yes (with formal presentation)
ASHP Code: 54035
NMS Match Code: 701056

Contact Information

For more information about the PGY2 Internal Medicine Residency Program, please contact:

Tenley E. Ryan, PharmD, BCPS
Clinical Pharmacy Specialist – Internal Medicine/Transitions of Care
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN

Phone: x6720
Email: tenley.ryan@va.gov

Pharmacy Residency Application

Application Process The Memphis VA Residency Programs participate in the ASHP-associated Pharmacy Online Residency Centralized Application Service (PhORCAS) for applications and the National Matching Service (NMS) for the residency matching process.

All of your application documents will need to uploaded to PhORCAS. For more information: www.ashp.org/phorcas.

PhORCAS application requirements for all programs: 

  • Curriculum vitae
  • College of pharmacy transcripts
  • Letter of intent (limited to 1 page)
  • Minimum of three (3) Letters of Recommendation (clinical preferred)

PGY1 Application Requirements

  • Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy
  • Application due: December 31
  • ASHP Program Code: 54200
  • NMS Match Code: 190213

PGY2 Internal Medicine Application Requirements

  • Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist
  • Application due: January 4 
  • ASHP Program Code: 54035
  • NMS Match Code: 701056

PGY2 Ambulatory Care Application Requirements

  • Application requirements: U.S. Citizenship, PharmD from ACPE-accredited college of pharmacy, completion of ASHP-accredited PGY1 residency program, licensure as a practicing pharmacist
  • Application due: December 31
  • ASHP Program Code: 54053
  • NMS Match Code: 735465

Clinical Pharmacy Staff

Riley Binkowski, Pharm.D.

Clinical Pharmacy Practitioner, Ambulatory Care  

EDUCATION:  

  • Pharm.D., Lipscomb University College of Pharmacy
  • PGY-1 Pharmacy Residency, Boise Veterans Affairs Medical Center, Boise, ID
  • PGY-2 Pharmacy Residency in Ambulatory Care, Boise Veterans Affairs Medical Center, Boise, ID

Jarred Bowden, Pharm.D., BCIDP, AAHIVP

Clinical Pharmacy Practitioner, Infectious Disease/Antimicrobial Stewardship, Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, Universiry of Florida Health Shands Hospital
  • PGY-2 Pharmacy Residency in Infectious Disease,Universiry of Florida Health Shands Hospital

Emily Brandl, Pharm.D., BCGP

Clinical Pharmacy Practitioner, Pain Management and Palliative Care

EDUCATION:   

Pharm.D., University of Tennessee College of Pharmacy

PGY-1 Pharmacy Residency, VAMC Memphis, TN


Dana Brown, Pharm.D.

Clinical Pharmacy Practitioner, Ambulatory Care - Anticoagulation

EDUCATION:   

  • Pharm.D., Xavier University College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN 

Krystin Butler, Pharm.D., MPH, BCPS

Clinical Pharmacy Practitioner, Home Based Primary Care  

EDUCATION:  

  • Pharm.D., Samford University McWhorter School of Pharmacy
  • PGY-1 Pharmacy Residency, Central Arkansas Veterans Healthcare System, Little Rock, AR
  • PGY-2 Pharmacy Residency in Geriatrics, Central Arkansas Veterans Healthcare System, Little Rock, AR   

Brandon Conaway, Pharm.D.

Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care

EDUCATION:   

  • Pharm.D., Union University College of Pharmacy
  • PGY-1 Pharmacy Residency, Baptist Memorial Hospital, Memphis, TN
  • PGY-2 PharmacyResidency in Critical Care, Regional One Health Medical Center, Memphis, TN

Stephanie Coveart, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Outpatient Mental Health; Assistant Professor, University of Tennessee College of Pharmacy   

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, Tennessee Valley Healthcare System, Nashville, TN
  • PGY-2 Pharmacy Residency in Psychiatry, Tennessee Valley Healthcare System, Nashville, TN

Cary Duncan, Pharm.D., BCPS
Associate Chief, Operations; Clinical Pharmacy Practitioner, Ambulatory Care

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Sidney D’Amico, Pharm.D.

Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care

EDUCATION:   

  • Pharm.D., University of Mississippi School of Pharmacy
  • PGY-1 Pharmacy Residency, Baptist Memorial Hospital, Memphis, TN
  • PGY-2 Pharmacy Residency in Internal Medicine, Barnes-Jewish Hospital, St. Louis, MO

Timmye Edwards, Pharm.D.

Clinical Pharmacy Practitioner, Research, Pharmacoeconomics

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Kevin Freeman, Pharm.D., BCNSP

Chief, Pharmacy Service; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Katie Frieling, Pharm.D., BCACP

Clinical Pharmacy Practitioner, Ambulatory Care

EDUCATION:   

  • Pharm.D., Union University School of Pharmacy
  • PGY-1 Pharmacy Residency, Ochsner Medical Center, New Orleans, LA
  • PGY-2 Ambulatory Care, University at Buffalo-Buffalo Medical Group, Buffalo, NY

Amanda R. Gillion, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Medical ICU; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:  

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency & PGY-2 Pharmacy Residency in Critical Care, Methodist University Hospital, Memphis, TN

Tommie Jo Guidry, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Spinal Cord Injury; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency & PGY-2 Pharmacy Residency in Internal Medicine, VAMC Memphis, TN

William Gust, Pharm.D.

Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care

EDUCATION:   

  • Pharm.D., University of Mississippi School of Pharmacy
  • PGY-1 Pharmacy Residency, G.V. (Sonny) Montgomery VAMC, Jackson, MS
  • PGY-2 Pharmacy Residency in Ambulatory Care, University of Mississippi School of Pharmacy

Jonathan M. Hoover, Pharm.D., BCPS, BCGP

Clinical Pharmacy Practitioner, Internal Medicine; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Amanda Howard-Thompson, Pharm.D., BCPS, CDE

Clinical Pharmacy Practitioner, Ambulatory Care and Women’s Clinic; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, LeBonheur Children’s Medical Center, Memphis, TN
  • PGY-2 Pharmacy Residency in Internal Medicine, Methodist University Hospital, Memphis, TN

Mark A. Howell, Pharm.D.

Clinical Pharmacy Practitioner, Ambulatory Care

EDUCATION:  

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy  Residency, VAMC Memphis, TN

Molly Hunt, Pharm.D.

Clinical Pharmacy Practitioner, Medicine/Surgery

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, University of Tennessee Medical Center, Knoxville, TN 
  • PGY-2 Pharmacy Residency in Critical Care, University of Tennessee Medical Center, Knoxville, TN 

Bryan Paul Jett, Pharm.D., BCPS, CGP

Clinical Pharmacy Practitioner, Ambulatory Care

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Angela Jolly, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Home-Based Primary Care;

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Seth Keller, Pharm.D., BCPS, CGP

Clinical Pharmacy Practitioner, Emergency Department

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Erin Latendresse, Pharm.D.

Clinical Pharmacy Practitioner, Ambulatory Care

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Community Pharmacy Residency, University of Mississippi, Jackson, MS
  • PGY-2 Pharmacy Residency in Ambulatory Care/Academia, University of Tennessee, Memphis, TN

Sara Layman, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Ambulatory Care; Assistant Professor, University of Tennessee College of Pharmacy

Education:       

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN
  • PGY-2 in Ambulatory Care, VAMC Memphis, TN

Jacob Marler, Pharm.D., BCCCP

Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care; Assistant Professor, University of Tennessee College of Pharmacy

Education:       

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, Methodist University Hospital, Memphis, TN
  • PGY-2 in Critical Care, Methodist University Hospital, Memphis, TN

Angela Marsella, Pharm.D., MBA

Clinical Pharmacy Practitioner, Outpatient Mental Health

EDUCATION:   

  • Pharm.D., McWhorter School of Pharmacy, Samford University
  • PGY-1 Community Pharmacy Residency, University of Wisconsin-Madison School of Pharmacy, Two Rivers, WI
  • PGY-2 Pharmacy Residency in Psychiatry, Tuscaloosa VA Medical Center, Tuscaloosa, AL

Shari May, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Spinal Cord Injury; Assistant Professor, University of Tennessee  College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Joseph Merkel, Pharm.D., BCACP

Clinical Pharmacy Practitioner, Ambulatory Care

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, Memphis VAMC, Memphis, TN
  • PGY-2 Pharmacy Residency in Ambulatory Care, Memphis VAMC, Memphis, TN

Anna Mitchell, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Academic Detailing  

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN
  • PGY-2 Pharmacy Residency in Internal Medicine, VAMC Memphis, TN           

Daniel Neu, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care

Education:       

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Jennifer Patton, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Pain Management, Pain POC/PACT Pain Champion

Education:       

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Dillon Perryman, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Mental Health/PCMHI

Education:       

  • Pharm.D., North Dakota State University, Fargo, ND
  • PGY-1 Pharmacy Residency, Chillicothe VAMC, Chillicothe, OH
  • PGY-2 Pharmacy Residency in Psychiatry, Chillicothe VAMC, Chillicothe, OH

Lauren Peyton, Pharm.D., BCACP, CDE

Clinical Pharmacy Practitioner, Ambulatory Care

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, Regional One Health, Memphis, TN

Ally Ponder, Pharm.D., MPH, BCPS

Clinical Pharmacy Practitioner, Cardiology ICU  

EDUCATION:  

  • Pharm.D., Samford University McWhorter School of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN
  • PGY-2 Pharmacy Residency in Internal Medicine, VAMC Memphis, TN   

Carly Rainey, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Mental Health/RRTP/SUD

Education:       

  • Pharm.D., University of Missouri, Kansas City School of Pharmacy
  • PGY-1 Pharmacy Residency, Chillicothe VAMC, Chillicothe, OH
  • PGY-2 Pharmacy Residency in Psychiatry, Chillicothe VAMC, Chillicothe, OH

Kothanur Rajanna, Masters Pharmacy, B.S. Pharmacy

Clinical Pharmacy Practitioner, Hematology/Oncology, Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • MPharm, All India Institute of Medical Sciences
  • B.S. Pharmacy, University of Tennessee College of Pharmacy  

Sloan Regen, Pharm.D., BPCS

Clinical Pharmacy Practitioner, Geriatrics; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, Michael E. DeBakey Medical Center, Houston, TX
  • PGY-2 Pharmacy Residency in Geriatrics, Central Arkansas VHS, Little Rock, AR

Caroline Richmond, Pharm.D., BCPP

Clinical Pharmacy Practitioner, Inpatient Mental Health

EDUCATION:   

  • Pharm.D., East Tennessee State University
  • PGY-1 Pharmacy Residency, St. Claire Regional Medical Center, Morehead, KY
  • PGY-2 Pharmacy Residency in Psychiatry, Lexington VA, Lexington, KY

Michael Rikard, Pharm.D., BCOP

Clinical Pharmacy Practitioner, Hematology/Oncology

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy

Kelly C. Rogers, Pharm.D., BCCP, FCCP, ACC

Clinical Pharmacy Practitioner, Cardiology; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:     

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, University of Virginia Health Sciences Center, Charlottesville, VA

Tenley Ryan, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Internal Medicine/Transitions of Care; Assistant Professor, University of Tennessee College of Pharmacy; PGY-2 Internal Medicine Residency Program Director

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN
  • PGY-2 Pharmacy Residency in Internal Medicine, VAMC Memphis, TN               

Shannon Stewart, Pharm.D.

Clinical Pharmacy Practitioner, Palliative Care; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency with Geriatrics Emphasis, VAMC Memphis, TN

Brooke Sullivan, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Ambulatory Care - Anticoagulation

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Joshua W. Sullivan, Pharm.D., BCPS, BCACP, BCGP

Associate Chief Clinical Programs, PGY1 Residency Program Director; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Melanie P. Swims, Pharm.D., BCPS

Clinical Pharmacy Practitioner, Ambulatory Care/Anticoagulation; Associate Professor, University of Tennessee College of Pharmacy

EDUCATION:     

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy  Residency, VAMC Memphis, TN

Camille Thornton, Pharm.D.

Clinical Pharmacy Practitioner, ID/HIV/GI/Hepatitis C; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency with Ambulatory Care Emphasis, VAMC Memphis, TN

Nicholas B. Townsend, Pharm.D., BCACP

Clinical Pharmacy Practitioner, Ambulatory Care; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Katie VanBuskirk, Pharm.D.

Clinical Pharmacy Practitioner, Home-Based Primary Care

EDUCATION:   

  • Pharm.D., University of Mississippi College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN

Katie Wassell, Pharm.D., BCACP

Clinical Pharmacy Practitioner, Ambulatory Care; PGY-2  Ambulatory Care Residency Program Director; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency, Memphis VAMC, Memphis, TN
  • PGY-2 Pharmacy Residency in Ambulatory Care, Memphis VAMC, Memphis, TN

Lindsey Wells, Pharm.D., BCCCP

Clinical Pharmacy Practitioner, Surgical ICU/Nutrition Support Service; Assistant Professor, University of Tennessee College of Pharmacy

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Pharmacy Residency & PGY-2 Pharmacy Residency in Critical Care, Regional One, Memphis, TN

Jessica Wooster Thomas, Pharm.D., BCACP

Clinical Pharmacy Practitioner, Ambulatory Care/Cardiology/Women’s Health

EDUCATION:   

  • Pharm.D., University of Tennessee College of Pharmacy
  • PGY-1 Community Pharmacy Residency, Albertsons Companies and Midwestern University

Angela Wuerger, Pharm.D., MPH

Clinical Pharmacy Practitioner, Ambulatory Care  

EDUCATION:  

  • Pharm.D., University of Kentucky College of Pharmacy
  • PGY-1 Pharmacy Residency, VAMC Memphis, TN
  • PGY-2 Pharmacy Residency in Ambulatory Care, VAMC Memphis, TN   

Pharmacy Facts and Preceptor/Resident Accomplishments

Memphis VA Medical Center Pharmacy Residency Facts

  • The PGY1 program has been ASHP accredited since 1963 and over 260 residents have graduated from the PGY1 program.
  • The PGY2 Internal Medicine Program has been accredited since 2016
  • The PGY2 Ambulatory Care Residency Program has been accredited since 2017
  • Approximately 67% of residents in the past 5 years and almost 75% of the residents within the past ten years have become board certified post-residency. Certifications include pharmacotherapy, geriatrics, psychiatry, critical care, oncology and ambulatory care.
  • Approximately 62.5% of residents have been hired as clinical pharmacy specialists and 35% as clinical pharmacists over the past 5 years. The remaining residents are currently PGY2 residents.
  • Approximately half of the residents in the previous 5 years have completed PGY2 residencies.
  • Approximately 87% of the residents in the past 5 years are currently involved in precepting students and residents.
  • Approximately 75% of our preceptors are board certified.

List of Resident and Preceptor National Presentations, Posters, Publications, Awards, Research Projects and Medication Use Evaluations

Publications:

Rogers KC, Oliphant CO, Finks SW.  Clinical efficacy and safety of cilostazol: a critical review of the literature.  Drugs 2015;75(4):377-395. doi: 10.1007/s40-3

Parker RB, Hu ZY, Meibohm B, Laizure SC. Effects of alcohol on human carboxylesterase drug metabolism. Clin Pharmacokinet 2015;54:627-38.

Spivey CA, Liu X, Qiao Y, Mardekian J, Parker RB, Phatak H, Masseria C, Kachroo S, Abdulsattar Y, Wang J. Stroke associated with discontinuation of warfarin therapy for atrial fibrillation. Curr Med Res Opin. 2015;31:2021-9

Spivey CA, Qiao Y, Liu X, Mardekian J, Parker RB, Phatak H, Claflin AB, Kachroo S, Abdulsattar Y, Chakrabarti A, Wang J. Discontinuation/Interruption of Warfarin Therapy in Patients with Nonvalvular Atrial Fibrillation. J Manag Care Spec Pharm. 2015;21:596-606.

Sullivan J, Jett B, Cradick M, Zuber J. Effect of Clinical Pharmacist Intervention on A1C reduction in Veteran Patients with Type 2 Diabetes in a Rural Setting. Annals of Pharmacotherapy 2016: 50(12);1023-1027. DOI 10.1177

Shah R, Rogers KC, Matin K, Askari R, Rao SV.  An updated comprehensive meta-analysis of bivalirudin versus heparin use in primary percutaneous coronary intervention.  Am Heart J 2016;171(1):14-24. doi: 10.1016/j.ahj.2015.10.006. Epub 2015 Oct 20.

Shah R, Rogers KC, Ahmed AJ, King BJ, Rao SV. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on acute stent thrombosis: meta-analysis of randomized controlled trials.  JACC Cardiovasc Interv. 2016;9(13):1313-20. doi: 10.1016/j.jcin.2016.03.031. Epub 2016 Jun 15.

Rogers KC, Shelton MP, Finks SW.   Reversal agents for direct oral anticoagulants:  understanding new and upcoming options.  Cardiol Rev 2016;24: 310–315.  doi: 10.1097/CRD.0000000000000118

Shah R, Matin K, Rogers KC, Rao SV. Effect of post-primary percutaneous coronary intervention bivalirudin infusion on net adverse clinical events and mortality: A comprehensive pairwise and network meta-analysis of randomized controlled trials.  Catheter Cardiovasc Interv 2017 Aug 1;90(2):196-204. doi: 10.1002/ccd.26859. Epub 2016 Nov 10.

McDonough SL, Alford, EL, Finks SW, Parker RB, Chisholm-Burns MA, Phelps SJ. Student Pharmacists’ perceptions of a composite examination in their first professional year. Am J Pharm Educ 2016;80:1-8.

Chen F, Hu ZY, Parker RB, Laizure SC. Measurement of caffeine and its three primary metabolites in human plasma by HPLC-ESI-MS/MS and clinical application. Biomed Chromatogr 2017;31:1-8.

Laizure SC, Meibohm B, Nelson K, Chen F, Hu Z, Parker RB. Comparison of caffeine disposition following administration by oral solution (energy drink) and inspired powder (AeroShot) in human subjects. Br J Clin Pharmacol 2017; 83:2687-2694.

Finks SW, Rogers KC. Idarucizumab (Praxbind®):  The first reversal agent for a direct oral anticoagulant.  Am J Med 2017;130(5):e195-e197.  doi: 10.1016/j.amjmed.2016.11.029. 2019 Jan;132(1):38-41. doi: 10.1016/j.amjmed.2018.06.028. Epub 2018 Jul 25.

Chen F, Zhang B, ParkerRB, Laizure SC. Clinical implications of genetic variation in carboxylesterase metabolism. Expert Opin Drug Metab Toxicol 2018; 14:131-142.

Chen F, Li DY, Zhang B, Sun JY, Sun F, Ji X, Qiu JC, Parker RB, Laizure SC, Xu J. Alterations of drug-metabolizing enzymes and transporters under diabetic conditions: What is the potential clinical significance? Drug Metab Rev 2018:50:369-97.

Shell A, Sullivan J. Acute Kidney Injury Following Methimazole Initiation: A Case Report. Journal of Pharmacy Practice 2018. DOI 10.1177.

Wassell K, Sullivan J, Jett B, Zuber J. Comparison of Clinical Pharmacy Specialists and Primary Care Physicians in Treatment of Type 2 Diabetes Mellitus in Rural Veteran Affairs Facilities. Am J Health-Syst Pharm, Resident’s Edition; 2018: 75, Supplement 1; S6-S12. DOI 10.2146/ajhp160905

Keough, L.A., Krauss, A. & Hudson, J.Q. Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis. Int J Clin Pharm (2018) 40: 1250

Kessler SG, Gillion AR, Pattanaik D, Rogers KC. Nitrite allergy and desensitization in a patient with refractory angina. J Allergy Clin Immunol Pract 2018. pii: S2213-2198(18)30663-9. doi: 10.1016/j.jaip.2018.10.006.

Meduri GU, Siemieniuk RAC, Ness RA, Seyler SJ. Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS. J Intensive Care. 2018 Aug 24;6:53. doi:10.1186/s40560-018- 0321-9. PMID: 30155260.

Ness RA, Hoover JM. Amiodarone-induced interstitial lung disease diagnosed after discontinuation of amiodarone – A case report. CP Case. 2018 May 25;1:016.

Rogers KC, Finks SW. A new option for reversing the anticoagulant effect of factor Xa inhibitors: andexanet alfa (Andexxa®). Am J Med 2019;132(1):38-41. doi: 10.1016/j.amjmed.2018.06.028. Epub 2018 Jul 25.

Shell A, Rajanna K, Keough L. Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard- Versus Extended-Interval Zoledronic Acid. Federal Practitioner (2019).

McDonnell CC, Rogers KC, Regen SM, Finks SW. The fall risk with alpha blockers given initial dose or elderly staus (FRAGILE) study. Annal of Pharmacotherapy, 2019. DOI: 10.1177/1060028019880305

Laizure SC, ZY Hu, Potter PM, Parker RB. Inhibition of carboxylesterase-1 alters clopidogrel metabolism and disposition. Xenobiotica 2019 DOI: 10.1080/00498254.2019.1612535

Laizure SC, Parker RB. Is genetic variability in carboxylesterase-1 and carboxylesterase-2 drug metabolism an important component of personalized medicine? Xenobiotica 2019 PMID: 31601149 DOI: 10.1080/00498254.2019.1678078

Layman SN, Guidry TJ, Gillion AR. Low-dose alteplase for the treatment of submassive pulmonary embolism: a case series. J of Pharm Prac, 2019. DOI: 10.1177/0897

Jacobs D, Wassel K, Guidry TJ, Sullivan J. Safety outcomes of atorvastatin 80 mg versus atorvastatin 40 mg in veteran population. Annals of Pharmacotherapy, 2019. DOI: 10.1177/1060028019877540

Ness RA, Bennett JG, Elliott WV, Gillion AR, Pattanaik DN. Impact of beta lactam allergies on antimicrobial selection in an outpatient setting. Allergy Asthma Proc. (submitted for publication)

Herndon K, Guidry TJ, Wassell K, Elliott W. Characterizing the safety profile of apixaban versus warfarin in moderate to severe chronic kidney disease at a veterans affairs hospital. Annals of Pharmacotherapy, 2019. DOI: 10.1177/1060002801987053

Mitchell AB, Ryan TE, Gillion AR, Wells LD, Muthiah MP.  Vitamin C and thiamine for sepsis and septic shock. Am J Med. May 2020

Rogers KC, Neu DW, Jaeger MC, Shah R, Finks SW. An Underappreciated and Prolonged Drug Interaction Leads to Ineffective Anticoagulation. South Med J. 2019;112(2):125‐129. doi:10.14423/SMJ.0000000000000926

Ness R, Gillion A, Elliott W, et al. “Impact of beta lactam allergies on antimicrobial selection in an outpatient setting. Southern Medical Journal. November 2019

Layman S, Elliott W, Regen S, Keough L. Implementation of a pharmacist-led transitional care clinic. Am J Health-Syst Pharm. 2020;77:966-971. DOI 10.1093/ajhp/zxaa080

Peters MJ, Marler JL, Kimmons LA, Ellingson S. Impact of fentanyl continuous infusion dosing strategies for analgosedation on medication usage. (Manuscript accepted to Hosp Pharm, pending publication).

Marler JL, Twilla JD, Finch CK, and Animalu C. Severe Ceftaroline-Induced Thrombocytopenia With Rapid Onset on Rechallenge. Ann Pharmacother. 2020 Feb;54(2):187-188.

Hamilton L, Suda K, Heidel R, McDonough S, Hunt M, Franks A.  The role of online learning in pharmacy education: A nationwide survey of student pharmacists.  Currents in Pharmacy Teaching and Learning, 2020.  DOI: 10.1016/j.cptl.2020.01.026

Hunt M, Yates J, Vega H, Heidel R, Buehler J.  Effects of postoperative gastrointestinal motility after neuromuscular blockade reversal with sugammadex versus neostigmine/glycopyrrolate in colorectal surgery patients.  Annals of Pharmacotherapy, 2020.  DOI: 10.1177/1060028020929061

Herndon K, Dewitt A, Gillion A, Pattanaik D. Infusion-related angioedema associated with infliximab-abda: Case report. Am J Health Syst Pharm. 2020 Oct 8:zxaa321. doi: 10.1093/ajhp/zxaa321. Epub ahead of print. PMID: 33031494.

Peters MJ, Ellingson SL, Kimmons LA, Marler JL. Impact of Fentanyl Continuous Infusion Dosing Strategies for Analgosedation on Medication Usage. Hosp Pharm. 2021 Oct;56(5):408-409. doi: 10.1177/0018578720925371. Epub 2020 May 22. PMID: 34720136.

McLean H, Wells L, Marler J. The effect of pre-arrest acid-base status on response to sodium bicarbonate and achievement of return of spontaneous circulation. Annals of Pharmacotherapy, 2021.  DOI

Mitchell A, Ness R, Bennett J, Bowden J, Elliott W, Gillion A, Pattanaik D. Implementation and Impact of a Beta-Lactam Allergy Assessment Protocol in a Veteran Population. Fed Pract. 2021 September;38(9):420-425.

Neu DW, Guidry TJ, Gillion AR, Pattanaik DN. Impact of Beta-lactam Allergies on Selection of Antimicrobials in an Inpatient Setting Among Veteran Population. Military Medicine, 2021 Mar. doi: 10.1093/milmed/usab004.

Madasu MK, Thang LV, Chilukuri P, Palanisamy S, Arackal JS, Sheahan TD, Foshage AM, Houghten RA, McLaughlin JP, McCall JG, Al-Hasani R. Peripheral kappa opioid receptor activation drives cold hypersensitivity in mice. The Journal of Pain, 22(5), 582. May 2021.

Marler J, Howland R, Kimmons LA, Mohrien K, Vandigo JE, Jones GM. Safety of Propofol When Used for Rapid Sequence Intubation in Septic Patients: A Multicenter Cohort Study. Hosp Pharm. 2022 Apr;57(2):287-293. doi: 10.1177/00185787211029547. Epub 2021 Jul 8. PMID: 35601715.

Mclean H, Wells L, Marler J. The Effect of Prearrest Acid-Base Status on Response to Sodium Bicarbonate and Achievement of Return of Spontaneous Circulation. Ann Pharmacother. 2022 Apr;56(4):436-440. doi: 10.1177/10600280211038393. Epub 2021 Aug 5. PMID: 34353142

Rogers KC.  Stable Atherosclerotic Disease. In: Baker WL, Bolesta S, Coons J et al., eds. Cardiology Pharmacy Preparatory Review and Recertification Course, 2021 ed. Lenexa, KS: American College of Clinical Pharmacy, 2021:135-172.

Rogers KC, Chilbert MR. Stable Atherosclerotic Disease. In: Jackevicius C, Patterson JH, eds. Cardiology Self-Assessment Program, 2021 Book 1. Atherosclerotic Heart Disease. Lenexa, KS:  American College of Clinical Pharmacy, 2021:57-90.

Caviness, LA, Wassell KM, Howard-Thompson A, Acute elevation of liver function test values following concomitant administration of dabigatran and primidone. Am J Health Syst Pharm, Volume 79, Issue 15, 1 2022, Pages 1250–1254. https://doi.org/10.1093/ajhp/zxac

Ritter S, Bowden J, Pattanaik D. A case of perioperative anaphylaxis presenting as hereditary alpha trytasemia. Ann Alllergy Asthma Immunol 2022. https://doi.org/10.1016/j.anai.2022.03.011

Richmond C, Coveart S. Neutropenia and leukopenia after cross taper from quetiapine to divalproex for the treatment of borderline personality disorder. Fed Pract, 2022;36(4). doi:10.12788/fp.0247

Rogers KC, Spinler S.  Acute Coronary Syndromes.  In: Chisholm-Burns MA, Schwinghammer TL Malone PM, et al, eds.  Pharmacotherapy: Principles and Practice.  6th ed.  New York: McGraw-Hill Companies, 2022:157-184.

Finks SW. Rogers KC.  Ischemic Heart Disease and Acute Coronary Syndrome. In: Franks AS, Boucher BA, Borja-Hart N, Waddell JA, eds. Complete Review for Pharmacy, 13th edition. American Pharmacists Association. Washington, DC. 2022:293-326.

Rogers KC. Dual antiplatelet therapy duration after percutaneous coronary interventions.  Content Update 2021. In: Chisholm-Burns MA, Schwinghammer TL Malone PM, et al, eds.  Pharmacotherapy: Principles and Practice.  5th ed.  New York: McGraw-Hill Companies. Available at www.accesspharmacy.com

Swims, Melanie P. Arthritis. In: Franks AS, Boucher BA, Borja-Hart N, Waddell JA, eds. Complete Review for Pharmacy, 13th edition. American Pharmacists Association. Washington, DC. American Pharmacist 2022: https://doi.org/10.21019/9781582123615.ch26.

Gales K, Hunt M, Marler J. The association of elevated lactate with multiple vasopressor administration in patients with septic shock: a retrospective cohort study. Journal of Pharmacy Practice 2022: 1-8. DOI: 10.1177/08971900221128640

Givens G, Neu D, Marler J. The risk of major bleeding with apixaban administration in patients with acute kidney injury. Annals of Pharmacotherapy 2022:1-8. DOI: 10.1177/10600280221129831

National/Regional Presentations:

McGarry, M. Lipid Management: Beyond Statins. Presented at Mis-South College of Clinical Pharmacy November 12, 2020.

Cole S. Thrombotic Complications in COVID-19. Presented at Memphis Area Pharmacist Society November 10, 2020.

Neil, S. Train Wrecks in Transitions of Care: Improving the Process. Presented at APhA Annual Meeting 2019 PharmTalks Pharmacy Innovations Worth Spreading March 22-25, 2019, Seattle, WA

Ness, R. Presented at APhA Annual Meeting 2019 PharmTalks Pharmacy Innovations Worth Spreading March 22-25, 2019, Seattle, WA

Reducing Concomitant Utilization of Opioids and Benzodiazepines. Presented at 2018 VHA Shark Tank Live as part of the VHA Innovator’s Network. Shark Tank 2018 Finalist project – top 19 out of 622 practices submitted. Washington, D.C.

Sullivan J, Jett BP, Cradick M, Zuber J Effect of Clinical Pharmacist Intervention on A1C Reduction in Veteran Patients with Type 2 Diabetes in a Rural Setting. Presented by M Cradick at the Mid-South Residency Conference, Memphis, TN April 2015.

Wassell K, Sullivan J, Jett B, Zuber J. Hemoglobin A1C Reduction in Veteran Patients with Type 2 Diabetes Managed by Clinical Pharmacy Specialists Compared to Primary Care Physicians in a Rural Setting. Presented by K Wassell at the Mid-South Residency Conference, Memphis, TN April 2016.

Wassell K, Sullivan J, Jett B, Zuber J. Hemoglobin A1C Reduction in Veteran Patients with Type 2 Diabetes Managed by Clinical Pharmacy Specialists Compared to Nurse Practitioners in a Rural Setting.

Presented by K Wassell at the Mid-South Residency Conference, Memphis, TN April 2017.

Presented at 2017 National Pharmacy Resident Project Forum (RPro4)

VanBuskirk K, Elliott W, Sullivan J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic. Presented by K VanBuskirk at the Mid-South Residency Conference, Memphis, TN April 2017

Neil S, Keough L, Elliott W, Sullivan J, Zuber J. Outcomes of a Pharmacist-led Transitional Care and Polypharmacy Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017. Presented by S Neil at the Mid-South Residency Conference, Memphis, TN April 2017

Germinario V, Sullivan J, Elliott W, Zuber J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c reduction Compared to Primary Care Providers in an Outpatient Women’s. Presented by V Germinario at the Mid-South Residency Conference, Memphis, TN April 2018.

Shell, A., Keough, L.A., Rajanna, K.  Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard- Versus Extended-Interval Zoledronic Acid. Presented at Mid-South Pharmacy Residents Conference (MPRC). April 2018

Neil, S., Keough, L.A., Elliott, W., Outcomes of a Pharmacist-Led Transitional Care Clinic. Presented at Mid-South Pharmacy Residents Conference (MPRC). April 2018

Hoover J, Lavender D, Wells L. Risk of Venous Thromboembolism on Thrice Daily Subcutaneous Unfractionated Heparin in a Higher Versus Lower BMI Hospitalized Veteran Population. Poster presented at: Midsouth Residency Conference; 2018 April  19-20; Memphis, TN.

Hoover J, Lavender D, Wells L. Risk of Venous Thromboembolism on Thrice Daily Subcutaneous Unfractionated Heparin in a Higher Versus Lower BMI Hospitalized Veteran Population. Poster presented at: Midsouth Residency Conference; 2018 April  19-20; Memphis, TN.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Presented at The Mid-South Residency Conference. Memphis, TN. April 2017.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Selected for platform presentation at the Society of Critical Care Medicine Annual Congress. Honolulu, HI. January 2017.

Ness RA, Elliott WV, Gillion AR, Bennett JG, Pattanaik DN. Impact of beta lactam allergies on selection of antimicrobials in an outpatient setting. Presented at The Mid-South Residency Conference. Memphis, TN. April 2017.

Bland P, Gillion AR, Wells LD.  Fluid Balance as a Prognostic Marker of Mortality in Septic Shock. Presented at The Mid-South Residency Conference. Memphis, TN. April 2016.

Gordon S, Gillion AR, Wells LD. Beta Blockers for the Prevention of Post Cardiac Surgery Development of Atrial Fibrillation.  Presented at The Mid-South Residency Conference. Memphis, TN. April 2017.

Neu DW, Guidry TJ, Gillion AR, et al. Impact of Beta-lactam Allergies on Selection of Antimicrobials in an Inpatient Setting. Presented at the Mid-South Pharmacy Residency Conference. Memphis, TN. April 2018.

Ness RA. Selecting solutions that are worth their salt. ACPE accredited.  Memphis Area Pharmacists Society meeting. Oct 2018.

Hoover, Jonathan. Tips to Facilitate Precepting Success. Teaching and Learning Program for the UTHSC College of Pharmacy

Hoover, Jonathan. New England Journal Resident 360 Journal Club Faculty Panelist. Served as the faculty pharmacy panelist on an interactive, web based journal club which included University of Tennessee Health Science Center physician faculty and residents, along with the authors of the “Partial Oral Treatment of Endocarditis (POET)” trial.  

Hoover, Jonathan. IPECS Course at University of Tennessee College of Pharmacy. Diabetic case overview.

Hoover, Jonathan. Rho Chi Residency Workshop. University of Tennessee College of Pharmacy. Discussed interviewing tips and tricks for interested Rho Chi P3 and P4 students (30-40 students).  Also incorporated mock interview process

Hoover, Jonathan. Community-Acquired Pneumonia Review. 30 minute presentation presented at morning report for interns, residents, and attending physicians from the Veterans Affairs Medical Center 

Hoover, Jonathan. Providing Effective Feedback and Documentation. Veterans Affairs Tennessee Valley Healthcare System as part of Preceptor Development Seminar.  Regional conference in Nashville, TN and was available as 1 hour CE for pharmacists 

Hoover, Jonathan. Providing Guidance Through Feedback and Evaluations. 1 hour presentation given for Pharmacotherapy Rounds to pharmacists and pharmacy residents at the Memphis Veterans Affairs Medical Center 

Hoover, Jonathan. Reality APPE: Real Life Experiences with Real Life Preceptors. University of Tennessee Health Science Center College of Pharmacy Preceptor Development Conference.  Regional conference in Memphis, TN and was available as 1 hour CE 

Hoover, Jonathan. Best Practices in Precepting Students and Standing Out on Rotation. Tennessee Pharmacist Association Emerging Leaders Program.  Regional meeting in Memphis, TN and was available as 1 hour CE for pharmacists. 

Hoover, Jonathan. Medication Based Therapy in Heart Failure. Presented for approximately 75 physicians for the Office of Graduate Medical Education for the University of Tennessee, Memphis  

Hoover, Jonathan. Hypertension Medications in CKD. Morning report for interns, residents, and attending physicians from the Veterans Affairs Medical Center 

Hoover, Jonathan. Antihypertensive Medication Considerations in Chronic Kidney Disease. University of Tennessee College of Medicine.

Swims, Melanie. RA, OA and Pharmacology of NSAIDs, University of Tennessee, 2018.

Swims, Melanie. DMARDS, University of Tennessee, 2018,

Swims, Melanie . Treatment of Psoriatic Arthritis and Immunosuppressants in Rheumatology, University of Tennessee, Rheumatology Conference, October 2018.

Swims, Melanie. Biologic DMARDS. University of Tennessee, Rheumatology Conference, October 2018.

Swims, Melanie. Traditional DMARDS, University of Tennessee, Rheumatology Conference, September 2018.

Swims, Melanie. NSAIDS, University of Tennessee, Rheumatology Conference, September 2018.

Swims, Melanie. Rheumatology Update, VAMC. Pharmacotherapy Rounds, July 2018.

Swims, Melanie. Rheumatology Pharmacotherapy: Pitfalls and Pearls. University of Tennessee, College of Medicine Noon Conference, May 2018. 

Rainey, Carly. VISN 10 Pharmacy Presentation over Conversion Disorder, September 2021. ACPE credit possible

Gillion, Amanda. ABLE Initiative. Presented at Specialty Care ICC National Committee Presentation. Virtual "Are you Ready and ABLE (allergy to beta lactam evaluation) CPPO podcast.

Gillion, Amanda. Virtual Allergy to Beta Lactam Evaluation - ABLE Project Presentation. Presented at VISN Pharmacy Executive (VPE) National CPPO meeting.

Gillion, Amanda. Virtual Beta Lactam Allergy Assessments (BLAA) and CPPO Task Force. Presented at National Antimicrobial Stewardship Task Force (ASTF) webinar (CE accredited). Virtual

Rogers, Kelly. Heart failure Update, 2021 Fall Therapeutics Seminar. Memphis, TN. November13, 2021.  ACPE UAN: 0064-0000-21-055-L01-P&T

Rogers, Kelly. Stable Atherosclerotic Disease”, 2021 ACCP/ASHP Cardiology Preparatory Review and Recertification Online Course. March 2021; 1.5 contact hours.

Sullivan Joshua and Ponnapula, Supriya. Monitoring and Evaluating Efficiency and Productivity Presented at national CPPO PACT/CPL Bootcamp. April 2022. CE accredited.

Posters:

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Presented at the American College of Clinical Pharmacy Annual Meeting. Hollywood, FL. October 2016

Rogers KC, Elliott NT, Greiner LE, Majaj N, Brenner M, Finks SW.  Appropriate monitoring to improve sotalol safety.   Program and Abstracts of the Annual Meeting of the American College of Clinical Pharmacy. 2016-Hollywood, FL.  Abstract #200

Farrar J, Chen F, Parker RB, Laizure SC. Effects of commonly prescribed drugs on dabigatran etexilate hydrolysis by carboxylesterases. Presented at the ACCP Annual Meeting, Phoenix, AZ, October 2017.

Shahreyar M, Morsy M, Heckle M, Rashid A, Ramanathan K, Rogers KC, Shah R.  An updated comprehensive meta-analysis of randomized trials evaluating the efficacy of stem cell therapy for refractory angina. American College of Cardiology 2017. Washington, D.C.; Presentation Number: 1178M-03. 

Morsy M, Heckle M, Shahreyar, Delgado G, Ramanathan K, Rogers KC, Shah R.  Shorter- versus longer-duration triple antithrombotic therapy for patients with coronary stents who require oral anticoagulation: an updated comprehensive meta-analysis. American College of Cardiology 2017.  Washington, D.C.; Presentation Number: 17-A-10191-ACC.

Atyia S, Rogers KC, Finks SW.  Effects of carvedilol prescribed at discharge in patients with cocaine-induced chest pain.  Program and Abstracts of the 52nd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 4, 2017 – Orlando, FL; Abstract # 2-336.

Jaeger M, Finks SW, Neu D, Rogers KC.  Transitions of care nightmare:  Induction of an enzyme leads to a reduction in anticoagulant efficacy.  Program and Abstracts of the 52nd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 4, 2017 – Orlando, FL; Abstract # 2-340.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Presented at the American College of Clinical Pharmacy Annual Meeting. Hollywood, FL. October 2016.

Neil S, Keough L, Elliott W, Sullivan J, Zuber J. Outcomes of a Pharmacist-led Transitional Care and Polypharmacy Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017. Presented by S Neil at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017.

Guidry TJ, Elliott WV, Gillion A, et al. Prediction of Invasive Candidiasis in a Veteran Population (PIVET): Validation of the Candida Score. Selected for platform presentation at the Society of Critical Care Medicine Annual Congress. Honolulu, HI. January 2017.

Kessler, S, Sullivan J, Zuber J. Comparison of Diabetes Outcome Disparities Between Men and Women.

Presented at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

Germinario V, Elliott W, Sullivan J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic. Co-Principal Investigator. Presented by V Germinario at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

VanBuskirk K, Elliott W, Sullivan J. Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017.

Presented by V Germinario at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

Neil S, Keough L, Elliott W, Sullivan J, Zuber J. Outcomes of a Pharmacist-led Transitional Care and Polypharmacy Clinic. Presented by K VanBuskirk at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017. Presented by S Neil at the American College of Clinical Pharmacy Annual Meeting, Phoenix, AZ October 2017.

Kessler, S, Sullivan J, Zuber J. Comparison of Diabetes Outcome Disparities Between Men and Women.

Presented at the American Society of Health-System Pharmacists Mid-Year Clinical Meeting, Orlando, FL December 2017.

Neu DW, Guidry TJ, Gillion AR, et al. Impact of Beta-lactam Allergies on Selection of Antimicrobials in an Inpatient Setting. Presented at the American College of Clinical Pharmacy Annual Meeting. Phoenix, AZ. October 2017.

Ness RA, Elliott WV, Gillion AR, Bennett JG, Pattanaik DN. Impact of beta lactam allergies on selection of antimicrobials in an outpatient setting. ACCP 2017. Poster #402.

Sullivan J, Berntson G, Freeman K, Patton J, Keough LA, Morton T. Reducing Concomitant Utilization of Opioids and Benzodiazepines. Presented at VHA Innovation Experience Demo Day, Washington, D.C. August 2018.

Rogers KC, Gabre E, Elliott N, Garner K, Finks SW.  VAMP-IT:  Veteran antiarrhythmic monitoring program-improving therapy. ACCP Updates in Therapeutics® 2018 – Jacksonville, Florida.  Abstract # F-19.

Jacobs D, Wassell K, Guidry T, Sullivan J. Safety and cardiovascular outcomes of high-intensity statin therapy with atorvastatin 80mg versus atorvastatin 40mg in the veteran population. Presented at the American College of Pharmacy Annual Meeting. Seattle, WA. October 2018.

Kessler SG, Gillion AR, Rogers KC, Pattanaik D.  Nitroglycerin desensitization protocol in nitroglycerin-induced urticaria.  Tennessee Society of Health System Pharmacists (TSHP) Midyear Meeting.  2018 - Nashville, TN.

Shah R, Nayyar M, Bondy BR, Chaudhry A, Butt AK, Shell A, Rogers KC. Effect of pre-procedural heparin administration on bivalirudin-based anticoagulation strategy during primary percutaneous coronary intervention: a network meta-analysis. American College of Cardiology March 12, 2018.  Orlando, FL. Presentation Number: 1287-261.

McDonnell CC, Rogers KC, Regen SM, Finks SW.  PRescribing Alpha blockers Including praZosin in the Elderly: the PRAIZE safety study. Program and Abstracts of the 53rd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 2, 2018 – Anaheim, CA.  Abstract # 1-349

Childress MB, Rogers KC, Finks SW. Ranolazine in refractory angina in a patient with end stage renal disease.  Program and Abstracts of the 53rd American Society of Health-System Pharmacists Mid-Year Clinical Meeting. December 2, 2018 – Anaheim, CA.  Abstract # 3-387

Boh, J., Coveart S., Keough LA., Patton J. Outcomes of an Opioid-Benzodiazepine Co-Prescribing Reduction Plan.  Presented at America Society of Health Systems Pharmacists (ASHP). December 2018

Shell, A., Keough, L.A., Rajanna, K.  Occurrence of Skeletal-Related Events in Multiple Myeloma and Prostate Cancer Patients Receiving Standard- Versus Extended-Interval Zoledronic Acid. Presented at Association of VA Hematology/Oncology (AVAHO). September 2018

Ye, S, Wells, LD. Gillion, AR. “Assessment of Pre-Admission Use of Calcium Channel Blockers Versus Beta Blockers in Patients Admitted with Sepsis” ACCP Global Meeting; Seattle, WA

Ye, SY. Dembski, VR. “Evaluation of a Pharmacy Student-Driven Medication Review on 30-Day Readmission Rates in a 49-Bed, Rural Community Hospital” ASHP Midyear Clinical Meeting; Orlando, FL

Clarkson M, Hoover J, Wells L. Rates of Venous Thromboembolism in Hospitalized Patients Receiving Unfractionated Heparin Thrice Daily in Higher Versus Lower BMI Patients. Poster presented at: American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; 2018 Oct 20-23; Seattle, WA.

Kessler, SG, Coveart S. Evaluation of Benzodiazepines Use in Patients with Post-Traumatic Stress Disorder. Presented by S. Kessler at the American College of Clinical Pharmacy Annual Meeting, Seattle, WA October 2018.

Ye S, Wells L, Gillion A. Assessment of Pre-Admission Use of Calcium Channel Blockers Versus Beta Blockers in Patients Admitted with Sepsis. Poster presented at: American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; 2018 Oct 20-23; Seattle, WA.

Clarkson M, Hoover J, Wells L. Rates of Venous Thromboembolism in Hospitalized Patients Receiving Unfractionated Heparin Thrice Daily in Higher Versus Lower BMI Patients. Poster presented at: American College of Clinical Pharmacy Global Conference on Clinical Pharmacy; 2018 Oct 20-23; Seattle, WA.

Ye S, Gillion AR, Well LD.  Assessment of Pre-Admission Use of Calcium Channel Blockers Versus Beta Blockers in Patients Admitted with Sepsis. Presented at the American College of Clinical Pharmacy Global Meeting. Seattle, WA. October 2018.

Herndon K, Guidry T, Wassell K, Elliott W. Safety Profile of Apixaban versus Warfarin in Veterans with Chronic Kidney Disease. Presented at the American College of Pharmacy Annual Meeting. Seattle, WA. October 2018.

Gillion A, Elliott W. Saving Lives One Assessment at a Time: Beta Lactam Allergy Assessments. Selected to be presented at VHA Innovation Demo Day. Washington DC. October 2019 (Also selected as VHA 2019 Shark Tank Semi-finalist).

Roberts AM, Rogers KC, Finks SW.  Ranolazine use in patients with chronic kidney disease +/- renal replacement therapy.  American College Clinical Pharmacy 2019 Virtual Poster Symposium, May 28, 2019.   Abstract #49256

Laizure S, He H, Parker RB. Alcohol consumption likely to increase clopidogrel antiplatelet activity. Presented at the ACCP Global Conference on Clinical Pharmacy, Seattle, WA, October 2018.

Herndon K, Dewitt A, Gillion AR. Hypersensitive reaction to infliximab-abda(biosimilar to infliximab): A Case report. Presented by K. Herndon at the (ACCP) Conference. New York, NY. October 2019.

McGlaughlin BT, Clarkson MK, Wassell KM, Finks SW, Rogers KC.  Safety and efficacy of direct-acting oral anticoagulants (DOACs) in the obese population. American College of Clinical Pharmacy Annual Meeting. October 28, 2019 - New York City, NY.  Abstract #51933

Mitchell AB, Guidry TJ, Gillion AR. Micafungin Resistance to Candida albicans in a Non-immunocompromised Host: A Case Report. Presented by A. Mitchell at the (ACCP) Conference. New York, NY. October 2019.

Lenahan SM, Guidry TJ, Bowden JE, Gillion AR. Evaluation of Outcomes in Invasive Candidiasis Treated with Micafungin in Obese versus Non-obese Patients. Presented at the American College of Pharmacy Annual Meeting. New York City, NY. October 2019.

Mitchell AB, Ryan TE, Gillion AR, Wells LD, Muthiah MP.  Vitamin C and thiamine for sepsis and septic shock. Presented by A. Mitchell at Society of Critical Care Medicine. San Diego, CA. February 2019.

Howard TG, Hamby A, Layman SN, Neu DW, Elliott WV. Alogliptin and heart failure outcomes in patients with type II diabetes. Poster presentation presented at the American College of Clinical Pharmacy Annual Meeting. New York, NY. October 2019.

Clarkson M, Hoover J, Elliott W, Eason J. High-dose daptomycin in ESRD as a part of triple antibiotic therapy in a patient with persistent MRSA bacteremia: case report. Presented at ACCP Annual Meeting, New York, NY. October 2019.

Howard G, Hamby A, Elliott W. Alogilptin and Heart Failure Outcomes in Patients with Type II Diabetes. Principle Investigator. Presented at the ACCP Annual Meeting. New York, NY. October 2019

Laizure SC, Parker RB. Does clopidogrel decrease the efficacy of carboxylesterase-1 prodrugs? Selected for presentation at the 2020 American Society of Pharmacology and Experimental Therapeutics Annual Meeting.

Mclean H, Wells L, Marler JL. The Effect of Sodium Bicarbonate on Return of Spontaneous Circulation in Patients with Cardiac Arrest. Virtual Presentation at ACCP Virtual Poster Symposium. May 26-27, 2020.

Keen W, Elliott W, Layman S, Sullivan J. Intravenous Iron Replacement in Hospitalized Heart Failure Patients. Presented at 2020 ACCP Virtual Symposium, May 2020.

Sela Cathright, Sloan Regen, Shannon Stewart. Assessment of adverse effects of zolpidem, zaleplon, eszopiclone in a Veteran population. Presented at 2020 CPNP Virtual Annual Meeting.

Phomakay V, Layman S, Swims M, Bennett J, Gupta S. Improvement in pneumococcal and herpes zoster vaccination rates of persons with chronic inflammatory disease on biologic immunosuppressive medications: A quality improvement project. Presented at UT Research Day, Memphis, TN January 2020.

Hunt M, Frisbee J, Winters S, Dudney T, Heidel R, Branca P.  Hydrocortisone and fludrocortisone versus hydrocortisone alone in critically ill patients with septic shock.  Platform presentation at Society of Critical Care Medicine Critical Care Congress.  Orlando, FL. February 2020.

Clarkson M, McGlaughlin B, Wassell K, Finks S, Rogers K. Safety and efficacy of direct-acatin oral anticoagulants (DOACs) in the obese population. Presented at 2020 ACC Virtual Meeting, March 2020.

McGarry M, Keough L, Wassell K. Assessment of renal outcomes with empagliflozin use in a veteran population with type 2 diabetes and proteinuria. Presented at 2020 ACCP Virtual Meeting, May 2020.

Slayton, M, Lerma J, Latendresse E, Ponnapula S. Comparing HbA1c lowering of SGLT2 inhibitors and GLP-1 agonist. Presented at TPA Winter Virtual Meeting, February 2020.

Hollums B, Ryan T, Wells L, VanBuskirk K. Comparison of direct oral anticoagulants and warfarin in patients with advanced liver disease. Presented at 2020 ACCP Virtual Symposium, May 2020.

Cole B, Brandl E, Keller A. Comparison of combined therapy with metronidazole versus piperacillin/tazobactam on postoperative infectious outcomes in acute cholecystitis patients undergoing cholecystectomy in a veteran population. Presented at 2020 ASHP Virtual Symposium, December 2020.

Gales K, Hunt M, Marler J. The effect of lactic acidosis on norepinephrine efficacy and the need for vasopressin therapy in patients with septic shock. Presented at 2021 ACCP Virtual Symposium, May 2021.

Lerma J, Guidry TJ, May S. Outcomes of a Pharmacist-Led Telehealth Clinic for Spinal Cord Injury Patients. Presented at 2020 ASHP Virtual Symposium, December 2020.

Thel M, Marler J, Ryan T. Effect of fluid resuscitation volume on outcomes in septic patients with heart failure. Presented at 2021 ASHP Virtual Symposium, December 2020.

Fong R, Bennett J, Bowden J. Impact of Pharmacist-driven Stewardship Efforts in the Emergency Department and Outpatients Clinics. Presented at 2020 ASHP Virtual Symposium, December 2020.

Cole S, Wells L, Gillion A. Steroids in Non-Critically Ill Hospitalized Patients with COVID-19 Requiring Supplemental Oxygen. Presented at 2020 ASHP Virtual Symposium, December 2020.

Butterfass C, Hunt M, Wells L. The effect of hyperglycemia on outcomes in hospitalized COVID-19 patients without diabetes receiving corticosteroids. Presented at 2021 ASHP Virtual Symposium, December 2021.

Caviness L, Sullivan J, Ponnapula S, Townsend N. Efficacy and Tolerability of a Formulary Conversion from Dulaglutide to Semaglutide in a Veteran Population. Presented at 2021 ASHP Virtual Symposium, December 2021.

Elliott J, Layman S, Regen S. Evaluation of the implementation of a pharmacist-led transitions of care discharge process in high-risk Veteran patients. Presented at 2021 ASHP Virtual Symposium, December 2021.

Gillis C, Stewart S, Guidry TJ, May S. Topical Diclofenac and Risk of Adverse Events. Presented at 2021 ASHP Virtual Symposium, December 2021.

Givens G, Neu D, Marler J. Does continuing apixaban in patients with acute kidney injury increase risk of major bleeding? Presented at 2021 ASHP Virtual Symposium, December 2021.

Morgan J, Wells L, Goggans M, Hunt M. Assessment of Outcomes in Hospitalized COVID-19 Patients Receiving Steroid Therapy with Well Controlled Versus Poorly Controlled Preexisting Diabetes. Presented at 2021 ASHP Virtual Symposium, December 2021.

Ponder A, Ryan T, Hoover J. Prescribing Patterns and Incidence of Gout Flares in a Veteran Population. Presented at 2021 ASHP Virtual Symposium, December 2021.

Thel M, Latendresse, Gillion A, Peyton L. Safety of Direct Acting Oral Anticoagulants in Patients with Active Gastrointestinal Cancer. Presented at 2021 ASHP Virtual Symposium, December 2021.

Wuerger A, Bowden J, Mitchell A, Marler J. Effect of Vancomycin Plus Piperacillin-tazobactam on the Incidence of Acute Kidney Injury in Obesity. Presented at 2021 ASHP Virtual Symposium, December 2021.

Butler BM, Parker RP, Rogers KC. Pharmacist-led initiative to increase guideline-directed management and therapies in veterans with PAD. American College of Clinical Pharmacy Annual Meeting Virtual Poster Session. October 2021.

Smith SE, Rogers KC, Newsome AS, Fulford M. Long-term retention of advanced cardiac life support (ACLS) knowledge after American Heart Association ACLS certification. American Association of Colleges of Pharmacy Virtual Pharmacy Education Annual Meeting. July 12-22, 2021.

Butler BM, Parker RP, Rogers KC. Pharmacist-led initiative to increase guideline-directed management and therapies in veterans with PAD. American College of Cardiology Cardiovascular Pharmacists Poster/Platform Virtual Poster Symposium, April 7, 2022.  

Butler BM, Parker RP, Rogers KC. Pharmacist-led initiative to increase guideline-directed management and therapies in veterans with PAD.  Tennessee Society of Hospital Pharmacist’s Winter Meeting.  February 2022 - Nashville, TN.  Student Posters Session

Analysis and Follow-Up of a Long-Acting Injectable Standard Operating Procedure Implementation at a Veterans Affairs Medical Center. Presented at CPNP Annual, April 2022.

Strength R, Patel J, Eason J, Bennett J, Bowden, J, Thomas-Gosain N. Biofiring on All Cylinders: Determining Optimal Utility of the BioFire Pneumonia Panel. The University of Tennessee Health Science Center and Memphis VA Medical Center. Poster presented at ID Week Annual Meeting 2021.

Byrd J, Bennett J, Bowden J, Eason J, Thomas-Gosain, N. Impact of COVID-19 on Inpatient Antibiotic Utilization Trends. The University of Tennessee Health Science Center and Memphis VA Medical Center. Poster presented at ID Week Annual Meeting 2021. 

Awards:
  • Outstanding Youth Alumnus for the Year, 2015, Jonathan Hoover
  • Preceptor of the Year, Union University, 2015, Jonathan Hoover
  • Student Government Association Executive Council Excellence in Teaching Award UTHSC, 2016, Jonathan Hoover
  • Preceptor of the Year, April 2018, Jonathan Hoover
  • Tennessee Society of Health-System Pharmacists Pharmacist of the Year, July 2018, Joshua Sullivan
  • American College of Clinical Pharmacy Ambulatory Care PRN Resident Travel Award – Sara Neil
  • American College of Clinical Pharmacy Ambulatory Care PRN Resident Travel Award  – Tommie Jo Guidry
  • Undersecretary of Health Excellence in Pharmacy Practice Award, 2018.
  • Tennessee Society of Health-Systems Pharmacists Residency of the Year award, 2019
  • Tennessee Pharmacist Association Excellence in Innovation Award, Amanda Gillion, July 2020.
List of Resident Projects Completed in last 5 years:
  • Digoxin Use in Veterans with Heart Failure in Normal Sinus Rhythm or Atrial Fibrillation
  • Appropriate Monitoring to Improve Sotalol Safety and Tolerability
  • Determining the Effects of a Hepatitis C Healthcare Provider Team on Sustained Virologic Response Rates in a Veteran Population
  • Fluid resuscitation in septic shock:  Fluid balance as a prognostic factor
  • Outcomes of a Pharmacist Led Hospital Discharge and Polypharmacy Clinic
  • Mortality Risk Associated with Methicillin-resistant and Methicillin-sensitive Staphylococcus aureus Bacteremia
  • Evaluation of Prolonged Antibiotic Therapy for Clostridium Difficile Due to Repeat Toxin PCR Testing
  • Antimicrobial Utilization Benchmarking
  • Effect of Clinical Pharmacist Intervention on A1c Reduction in Patients with Type II Diabetes in a Rural Setting
  • Clinical outcomes in veteran patients with Staphylococcus aureus bacteremia
  • Retrospective Chart Review of Spinal Cord Injury (SCI) Patients with Asymptomatic Bacteriuria Undergoing Traumatic Genitourinary Procedures: An Effort to Determine Appropriate Antimicrobial Prophylactic Duration
  • Prediction of Invasive Candidiasis in a Veteran Population (PIVET):Validation of the Candida Score
  • Beta Blockers for the Prevention of Post Cardiac Surgery Development of Atrial Fibrillation
  • Impact of Long Term Opioid Therapy on Functional Status Among Chronic Pain Patients
  • Effect of Clinical Pharmacist Intervention on Hemoglobin A1c Reduction Compared to Primary Care Providers in an Outpatient Women’s Clinic
  • Effect of Clinical Pharmacist on A1C reduction in an Outpatient Rural Setting Compared to Traditional Management by a Primary Care Provider.  
  • Implementation of a Medicine Discharge Clinic and Outcomes
  • Appropriate Monitoring to Improve Amiodarone Safety and Tolerability
  • The Effects of Albiglutide in Addition to Basal/Bolus Insulin Therapy in Veterans with Uncontrolled Type II Diabetes Mellitus
  • Comparison of Hemoglobin A1c Reduction in Veteran Patients with Type II Diabetes Managed by Clinical Pharmacists Compared to Nurse Practitioners in a Rural Setting
  • Comparison of Hemoglobin A1c Reduction in Patients with Type II Diabetes Managed by Clinical Pharmacists versus Primary Care Providers
  • VAMP-IT: Veteran Antiarrhythmic Monitoring Program-Improving Therapy
  • Rates of Venous Thromboembolism in Hospitalized Patients Receiving Unfractionated Heparin Thrice Daily in Higher Versus Lower BMI Patients
  • Outcomes of a Pharmacist-Led Transitional Care Clinic (TCC)
  • Assessment of Diabetes Outcome Disparities Between Male and Female Veterans Effect of Clinical Pharmacists on Hemoglobin A1c Reduction in an Outpatient Ambulatory Care Women’s Clinic
  • Risk of Venous Thromboembolism on Thrice Daily Subcutaneous Unfractionated Heparin in a Higher Versus Lower BMI Hospitalized Veteran Population
  • Evaluation of Proton Pump Inhibitors’ Association with QT Prolongation
  • Impact of beta lactam allergies on antimicrobial selection in an outpatient setting
  • Impact of beta lactam allergies on antimicrobial selection in an inpatient setting
  • Evaluation of Bisphosphonate Use in Multiple Myeloma Patients
  • Safety profile of apixaban versus warfarin in Veterans with chronic kidney disease
  • Evaluation of Opioid Use Reduction in Patients with High Morphine Equivalent Daily Doses (MEDD)
  • Assessment of pre-admission use of calcium channel blockers versus beta blockers in patients admitted with sepsis
  • Vitamin C, Thiamine and Hydrocortisone in the Treatment of Veteran Patients with a Primary Diagnosis of Septic Shock
  • Clinical impact and cost analysis of a beta lactam allergy assessment protocol in a Veteran population
  • PRescribing Alpha blockers Including praZosin in the Elderly: the PRAIZE safety study
  • Safety outcomes of atorvastatin 80mg versus atorvastatin 40mg in a veteran population
  • Reduction of Opioid and Benzodiazepine Combination Program Outcomes
  • Safety comparison of factor Xa inhibitors and warfarin in patient with cirrhosis
  • Assessment of adverse effects of zolpidem, zaleplon, eszopiclone in a veteran population
  • Efficacy comparison of SGLT2 inhibitors and GLP1 agonists in patients with poorly controlled diabetes
  • The role of sodium bicarbonate in cardiac arrest patients
  • Assessment of Renal Outcomes with Empagliflozin Use in a Veteran Population with Type 2 Diabetes
  • Effects of Intravenous Iron in Patients with Heart Failure
  • Assessment of Heart Failure Outcomes in Patients on DPP4 Inhibitors Alogliptin and Saxagliptin
  • Treatment of Candidemia with Micafungin in Higher Versus Lower BMI patients
  • Safety and efficacy of DOACs in the obese population
  • Impact of Beta Lactam Allergy Assessment Protocol in a Veteran Population
  • Incidence of gout flare upon initiation of urate lowering therapy with and without anti-inflammatory prophylaxis
  • Assessment of outcomes in hospitalized COVID19 patients receiving steroid therapy with well controlled versus poorly controlled preexisting diabetes
  • The effect of hyperglycemia on outcomes in hospitalized COVID19 patients without diabetes receiving corticosteroids
  • Does continuing apixaban in patients with AKI increase bleed risk?
  • Does zosyn increase rates of AKI in septic patients who are obese?
  • Safety of DOACs in patients with active GI cancer
  • A1c Reduction in a Veteran Population On Semaglutide versus Dulaglutide  
  • Evaluation of the implementation of a pharmacist-led transitions of care discharge process in high risk Veteran patients
  • Topical Diclofenac and Risk of Adverse Events 
  • Assessment of outcomes in hospitalized COVID19 patients receiving steroid therapy with well controlled versus poorly controlled preexisting diabetes
  • The effect of hyperglycemia on outcomes in hospitalized COVID19 patients without diabetes receiving corticosteroids
  • Optimal vancomycin weight-based dosing to achieve AUC 400-600 stratified by BMI
  • Impact of stewardship intervention on antibiotic prescribing prior to dental procedures in patients with joint replacement
  • Significance of the Loading Phase Duration of Apixaban for VTE or PE After Initial Anticoagulation Treatment with  Heparin or Lovenox
  • Pharmacist-Led Initiative to Increase Guideline-Directed Therapies in Veterans with PAD
  • Risk of Acute Kidney Injury after Addition of Empagliflozin to Background Congestive Heart Failure Therapy in a Veteran Population
  • Entresto Utilization and Impact on Heart Failure Readmissions in African American or Patients with Obesity
  • Pharmacist-Led Initiative to Improve Diabetes Management in Patients with Cardiovascular Disease
List of Resident Medication Use Evaluations Completed in last 5 years:
  • Erythropoietin Use
  • Colchicine Prescribing at VAMC
  • Evaluation of Metoclopramide Use
  • Dronedarone in Patients with Heart Failure
  • Incidence of Thrombosis with use of Megestrol
  • Pneumococcal Vaccines
  • Opioid-Induced Hypogonadism
  • Time to First Dose (“NOW”) Antibiotics
  • Evaluation of Niacin Use
  • Monitoring Frequency for Spironolactone and Eplerenone
  • Metformin Prescriptions in Patients with Serum Creatinine Greater than 1.5
  • Memantine in Patients with Alzheimer’s Disease
  • Testosterone Use in a Veteran Population
  • Nitrofurantoin Use in a Veteran Population
  • Effect of Oral Non-steroidal Anti-inflammatory Drugs (NSAID) in Combination with Topical Diclofenac Gel
  • Vancomycin Dosing - Without Levels, Without Documentation
  • Tolerance of Beta-Lactam Antibiotics After Entry of Beta-Lactam Allergy
  • Evaluation of Metoclopramide Use
  • Effect on INR Control with Conversion to New Generic Warfarin Formulation
  • Time to Administration of Now Doses of Vancomycin and Piperacillin-Tazobactam among Inpatients at the Memphis VAMC
  • Prescribing of Immediate Acting Antiepileptic Drugs
  • Drug Use Evaluation of Triple Antithrombotic Therapy
  • Evaluating First Dose (“NOW”) of Vancomycin and Zosyn
  • Time to First Dose (“NOW”) Antibiotics
  • Evaluation of Outcomes in Patients with Heart Failure who are Prescribed NSAIDs
  • Lithium Monitoring and Safety
  • Amikacin Monitoring and Safety
  • Electrocardiogram Monitoring in the Setting of Methadone Treatment
  • Monitoring of Direct Oral Anticoagulants
  • Increased Eylea Use in the Ophthalmology Clinic
  • Albiglutide in Patients with Diabetes Mellitus
  • Direct Oral Anticoagulants and Liver Injury
  • Benzodiazepine Utilization in Patients with Post-Traumatic Stress Disorder
  • Veteran’s Transitioned from Three Times Daily to Twice Daily Pregabalin Dosing
  • Glucocorticoid Induced Osteoporosis
  • Lithium in Patients with Psychiatric Disorders
  • Prescribing Trends of Antibiotics for Prophylaxis Around Prostate Biopsy Performed at the Memphis Veterans Affairs Medical Center
  • Pneumococcal Vaccination in Rheumatoid Arthritis Patients
  • Cost-Effectiveness of SGLT2 inhibitors and GLP1 receptor agonists
  • Febuxostat and Risk of Cardiovascular Events
  • Concomitant Use of IM Olanzapine and Benzodiazepines
  • Daptomycin CFU Evaluation
  • Treatment of Asymptomatic Bacteriuria
  • Vancomycin Removal via Hemodialysis Filtration
  • Appropriate Dosing of Simvastatin when used with Interacting Drugs
  • Assessment of SSRI and SNRI Combination Therapy
  • Concomitant Use of IM Olanazapine and Benzodiazepines
  • Daptomycin Criteria for Use
  • Peri-procedural antibiotic use in patients with listed beta lactam allergies
  • Benzodiazepine use in patients with Post Traumatic Stress Disorder
  • Appropriate Dose Transition of Ticagrelor After 1 Year Post-Acute Coronary Event
  • Criteria for Use and Rate of Hospitalization with Sacubitril/Valsartan (Entresto)
  • Evaluation of ADRs and Mortality Among Remdesivir Patients to Date
  • Drug Use Evaluation Metformin Dosing with Concurrent Ranolazine
  • Correlation of Initial Procalcitonin and Culture Results in Patients with Infection
  • Accuracy of the biofire BCID2 panel for both organisms and resistance genes through correlation with blood cultures
  • Correlation of Initial Procalcitonin and Culture Results in Patients with COVID-19
  • Use of Antibiotics in Patients with COVID-19
  • Failure of Wixela® in patients with COPD
  • Quetiapine Prescribing Practices and PADR Requirements

More About Memphis

You can learn more about the Memphis, Tennessee area by browsing to the links below. But remember, these links will take you outside the Department of Veterans Affairs Website and VA does not endorse and is not responsible for the content on these sites.

Contact Information

For more information about the PGY1 or PGY2 Ambulatory Care Residency Program, please contact:

Joshua Sullivan, PharmD, BCACP, BCPS, BCGP
Associate Chief, Clinical Pharmacy Programs
PGY1 Pharmacy Residency Program Director
PGY2 Ambulatory Care Residency Program Director
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN
Phone: 
Email: josh.sullivan@va.gov

For more information about the PGY2 Internal Medicine Residency Program, please contact:

Tenley E. Ryan, PharmD, BCPS
Clinical Pharmacy Specialist – Internal Medicine/Transitions of Care
Memphis VA Medical Center
1030 Jefferson Ave
Memphis, TN
Phone:  x6720
Email: tenley.ryan@va.gov